Notice of Proposed Sale · 144
Takeda Pharmaceutical Co Ltd
TKPHFOTCEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Takeda Pharmaceutical Company Limited
- Issuer CIK
- 0001395064
- SEC file number
- 001-38757
- Phone
- 81-3-3278-2111
- Person for whose account securities are to be sold
- Nicola Greenway
- Relationships to issuer
- Chief Human Resources Officer
- Street
- 1-1, Nihonbashi-Honcho 2-chome
- Street (continued)
- Chuo-ku,
- City
- Tokyo
- State / country code
- M0
- Postal code
- 103-8668
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| American Depositary Shares (ADSs) | 34,603 | 578,562.16 | 158,131,870 | 08/07/2026 | NYSE | Interactive Brokers LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- Interactive Brokers LLC
- Street
- One Pickwick Plaza
- City
- Greenwich,
- State / country code
- CT
- Postal code
- 06830
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| ADSs | 07/28/2023 | Restricted Stock Unit Awards - Vested | Takeda Pharmaceutical Company Limited | 11,912 | N | 07/28/2023 | Compensation |
| ADSs | 07/30/2024 | Restricted Stock Unit Awards - Vested | Takeda Pharmaceutical Company Limited | 14,816 | N | 07/30/2024 | Compensation |
| ADSs | 07/31/2025 | Restricted Stock Unit Awards - Vested | Takeda Pharmaceutical Company Limited | 18,866 | N | 07/31/2025 | Compensation |
| ADSs | 04/13/2023 | Employee Stock Purchase Plan | Takeda Pharmaceutical Company Limited | 132 | N | 04/13/2023 | Cash |
| ADSs | 10/11/2023 | Employee Stock Purchase Plan | Takeda Pharmaceutical Company Limited | 142 | N | 10/11/2023 | Cash |
| ADSs | 04/10/2024 | Employee Stock Purchase Plan | Takeda Pharmaceutical Company Limited | 159 | N | 04/10/2024 | Cash |
| ADSs | 04/10/2025 | Employee Stock Purchase Plan | Takeda Pharmaceutical Company Limited | 152 | N | 04/10/2025 | Cash |
| ADSs | 10/10/2024 | Employee Stock Purchase Plan | Takeda Pharmaceutical Company Limited | 165 | N | 10/10/2024 | Cash |
| ADSs | 04/13/2026 | Employee Stock Purchase Plan | Takeda Pharmaceutical Company Limited | 225 | N | 04/13/2026 | Cash |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| Nicola Greenway | ADSs | 07/13/2026 | 7,348 | 123,072.06 |
Seller — prior-sale row 1, entry 1
- Name
- Nicola Greenway
- Street
- 500 KENDALL STREET
- City
- CAMBRIDGE,
- State / country code
- MA
- Postal code
- 02142
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Remarks
Sale during the past 3 months was conducted in order to satisfy tax obligations in connection with share vesting effective July 13, 2026. Date of such sale reflects the date on which the administrative agent initiated this process, and such sales may not have settled as of the date hereof.
Notice signature
- Notice date
- 08/06/2026
- Signed
- /s/ Samuel Ntonme, by power of attorney for Nicola Greenway